Tim Wiltshire
0000-0001-5960-4034
Publication & Citation Trends
Publications
0 total
RYK Gene Expression Associated with Drug Response Variation of Temozolomide and Clinical Outcomes in Glioma Patients OA
Cited by 4
Semantic Scholar
Pharmacogenomic Analyses Implicate B Cell Developmental Status and MKL1 as Determinants of Sensitivity toward Anti-CD20 Monoclonal Antibody Therapy OA
Cited by 0
Semantic Scholar
MKX-AS1 Gene Expression Associated with Variation in Drug Response to Oxaliplatin and Clinical Outcomes in Colorectal Cancer Patients OA
Cited by 2
Semantic Scholar
The feasibility and potential of pharmacogenetics to reduce adverse drug events in nursing home residents OA
Cited by 2
Semantic Scholar
Model‐Based Prediction of Irinotecan‐Induced Grade 4 Neutropenia in Advanced Cancer Patients: Influence of Demographic and Clinical Factors OA
Cited by 5
Semantic Scholar
Evaluation of the performance of a prior tacrolimus population pharmacokinetic kidney transplant model among adult allogeneic hematopoietic stem cell transplant patients OA
Cited by 7
Semantic Scholar
North Carolina's multi-institutional pharmacogenomics efforts with the NC precision health collaborative.
Cited by 3
Semantic Scholar
Application of a Tacrolimus Population Pharmacokinetic Model to Adult Allogeneic Hematopoietic Stem Cell Transplant Patients OA
Cited by 0
Semantic Scholar
Research Topics
Genetic Mapping and Diversity in Plants and Animals
(20)
Pharmacogenetics and Drug Metabolism
(13)
Genetic and phenotypic traits in livestock
(10)
Gene expression and cancer classification
(10)
Pain Mechanisms and Treatments
(7)
Affiliations
University of North Carolina at Chapel Hill
Scripps Research Institute
Genomics Institute of the Novartis Research Foundation
Cedars-Sinai Medical Center
Novartis (Switzerland)